The short version
20 companies supply this market — deep enough that no single failure threatens the supply. The generic price has held steady around $0.0689 per unit over the past year. The brand runs $9.27 per unit — 135× more.
Market view
montelukast sodium · Tablet, Chewable
111 marketed package NDCs · 20 active manufacturers
Most dispensed: 5 mg · Tablet, Chewable · #30 tablet, chewables/bottle · 4 mg · Tablet, Chewable · #30 tablet, chewables/bottle · 10 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle · 10 mg · Tablet, Film Coated · #90 tablet, film coateds/bottle
Price range and competition
RSS: changes for this drugpriced separately — they are not the same market
Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $0.0689 · middle half $0.0689–$0.0738 · full range $0.0689–$0.0738 · 33 products · 20 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for montelukast sodium, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- SingulairAug 19, 2026Price downNADAC $9.21664 → $9.21241 per unit (-0.05%)
- SingulairAug 19, 2026Price downNADAC $9.21664 → $9.21241 per unit (-0.05%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.04027 → $0.04154 per unit (+3.15%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.04027 → $0.04154 per unit (+3.15%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.04027 → $0.04154 per unit (+3.15%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.04027 → $0.04154 per unit (+3.15%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.06778 → $0.06892 per unit (+1.68%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.0689 → $0.07384 per unit (+7.17%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.06778 → $0.06892 per unit (+1.68%)
- Montelukast SodiumAug 19, 2026Price upNADAC $0.06778 → $0.06892 per unit (+1.68%)
Same drug class
Other molecules FDA puts in Leukotriene Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Montelukast sodium in shortage right now?
- No. FDA does not currently list Montelukast sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Montelukast sodium?
- 42 companies have marketed Montelukast sodium in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Montelukast sodium cost?
- The typical pharmacy pays about $0.0689 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
Shortage reports for this molecule
- Planned discontinuation — Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01)Nov 17, 2025
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.